VIENNA (GenomeWeb) – Five independent studies presented at the European Congress of Clinical Microbiology and Infectious Disease (ECCMID) here this week provide the most compelling data to date regarding the accuracy, speed, and ease of use of Meridian Bioscience's molecular malaria assay.
The presentations, which also coincide with World Malaria Day today, provide further support for the test, Illumigene Malaria, as a tool for routine screening of travelers in non-endemic areas of the world who are returning from high-burden disease regions.